BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32225167)

  • 21. Systematic evaluation of differential splicing tools for RNA-seq studies.
    Mehmood A; Laiho A; Venäläinen MS; McGlinchey AJ; Wang N; Elo LL
    Brief Bioinform; 2020 Dec; 21(6):2052-2065. PubMed ID: 31802105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved detection of aberrant splicing with FRASER 2.0 and the intron Jaccard index.
    Scheller IF; Lutz K; Mertes C; Yépez VA; Gagneur J
    Am J Hum Genet; 2023 Dec; 110(12):2056-2067. PubMed ID: 38006880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing.
    Soreq L; Guffanti A; Salomonis N; Simchovitz A; Israel Z; Bergman H; Soreq H
    PLoS Comput Biol; 2014 Mar; 10(3):e1003517. PubMed ID: 24651478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and splicing mediate distinct biological signals.
    Dam SH; Olsen LR; Vitting-Seerup K
    BMC Biol; 2023 Oct; 21(1):220. PubMed ID: 37858135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRSD: A quantitative approach for assessing suitability of RNA-seq in the investigation of mis-splicing in Mendelian disease.
    Rowlands CF; Taylor A; Rice G; Whiffin N; Hall HN; Newman WG; Black GCM; ; O'Keefe RT; Hubbard S; Douglas AGL; Baralle D; Briggs TA; Ellingford JM
    Am J Hum Genet; 2022 Feb; 109(2):210-222. PubMed ID: 35065709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotype-tissue expression and exploration (PTEE) resource facilitates the choice of tissue for RNA-seq-based clinical genetics studies.
    Velluva A; Radtke M; Horn S; Popp B; Platzer K; Gjermeni E; Lin CC; Lemke JR; Garten A; Schöneberg T; Blüher M; Abou Jamra R; Le Duc D
    BMC Genomics; 2021 Nov; 22(1):802. PubMed ID: 34743696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of RNA splicing analysis null models for post hoc filtering of Drosophila head RNA-Seq data with the splicing analysis kit (Spanki).
    Sturgill D; Malone JH; Sun X; Smith HE; Rabinow L; Samson ML; Oliver B
    BMC Bioinformatics; 2013 Nov; 14():320. PubMed ID: 24209455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outlier detection for improved differential splicing quantification from RNA-Seq experiments with replicates.
    Norton SS; Vaquero-Garcia J; Lahens NF; Grant GR; Barash Y
    Bioinformatics; 2018 May; 34(9):1488-1497. PubMed ID: 29236961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential splicing analysis based on isoforms expression with NBSplice.
    Merino GA; Fernández EA
    J Biomed Inform; 2020 Mar; 103():103378. PubMed ID: 31972288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ARH-seq: identification of differential splicing in RNA-seq data.
    Rasche A; Lienhard M; Yaspo ML; Lehrach H; Herwig R
    Nucleic Acids Res; 2014 Aug; 42(14):e110. PubMed ID: 24920826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of RNA-seq data reveals the complexity of the transcriptome in Brassica rapa.
    Tong C; Wang X; Yu J; Wu J; Li W; Huang J; Dong C; Hua W; Liu S
    BMC Genomics; 2013 Oct; 14():689. PubMed ID: 24098974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
    Brandão RD; Mensaert K; López-Perolio I; Tserpelis D; Xenakis M; Lattimore V; Walker LC; Kvist A; Vega A; Gutiérrez-Enríquez S; Díez O; ; de la Hoya M; Spurdle AB; De Meyer T; Blok MJ
    Int J Cancer; 2019 Jul; 145(2):401-414. PubMed ID: 30623411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data.
    Feng H; Li T; Zhang X
    BMC Genomics; 2018 Aug; 19(Suppl 6):564. PubMed ID: 30367578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Slinker: Visualising novel splicing events in RNA-Seq data.
    Schmidt B; Cmero M; Ekert P; Davidson N; Oshlack A
    F1000Res; 2021; 10():1255. PubMed ID: 35035899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.
    Pan Q; Shai O; Lee LJ; Frey BJ; Blencowe BJ
    Nat Genet; 2008 Dec; 40(12):1413-5. PubMed ID: 18978789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq.
    Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G
    BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome landscape of the human placenta.
    Kim J; Zhao K; Jiang P; Lu ZX; Wang J; Murray JC; Xing Y
    BMC Genomics; 2012 Mar; 13():115. PubMed ID: 22448651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal dynamics in meta longitudinal RNA-Seq data.
    Oh S; Li C; Baldwin RL; Song S; Liu F; Li RW
    Sci Rep; 2019 Jan; 9(1):763. PubMed ID: 30679697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome analysis reveals differential splicing events in IPF lung tissue.
    Nance T; Smith KS; Anaya V; Richardson R; Ho L; Pala M; Mostafavi S; Battle A; Feghali-Bostwick C; Rosen G; Montgomery SB
    PLoS One; 2014; 9(3):e92111. PubMed ID: 24647608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.
    Kaya C; Dorsaint P; Mercurio S; Campbell AM; Eng KW; Nikiforova MN; Elemento O; Nikiforov YE; Sboner A
    Thyroid; 2021 Apr; 31(4):589-595. PubMed ID: 32948110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.